Akèy › Kansè nan tete › Pennsylvania › Pittsburgh
Etid klinik pou Kansè nan tete nan Pittsburgh, PA
39 etid pou Kansè nan tete ap chèche patisipan nan sit nan ak bò kote Pittsburgh (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Ap rekriteFaz 1/2
- University of Pittsburgh Medical Center, Pittsburgh
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Ap rekriteFaz 3
- Allegheny Health Network, Pittsburgh
Distance-Based Exercise to Preserve Function and Prevent Disability
Ap rekrite
- UPMC Hillman Cancer Center, Pittsburgh
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
Ap rekriteFaz 2
- University of Pittsburgh (UPMC), Pittsburgh
Prospective Study of EXErcise Regimens After Treatment for Breast Cancer for Hypertrophy and Conditioning
Ap rekriteEtid obsèvasyon
- Allegheny General Hospital, Pittsburgh
A Pilot Study Assessing Myokines During an EXErcise Regimen After Treatment for Breast Cancer
Ap rekrite
- AHN Allegheny General Hospital, Pittsburgh
- Allegheny General Hospital, Pittsburgh
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
Ap rekriteFaz 1
- Research Site, Pittsburgh
EXERT-BC Protein: Protein Supplementation to Improve Body Composition After Treatment for Breast Cancer
Ap rekrite
- AHN Allegheny General Hospital, Pittsburgh
- AHN Allegheny General Hospital, Pittsburgh
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
Ap rekriteFaz 3
- University of Pittsburgh Medical Center Magee-Womens Hospital ( Site 0058), Pittsburgh
Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy
Ap rekrite
- University of Pittsburgh Cancer Institute (UPCI), Pittsburgh
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Ap rekrite
- Allegheny (AHN), Pittsburgh
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Ap rekriteFaz 1
- University of Pittsburgh Medical Center, Pittsburgh
Identifying Patterns in the Breath of Individuals With Breast Cancer
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Weinstein Imaging Associates, Pittsburgh
Active Surveillance in Older Women With ER+ Breast Cancer
Ap rekriteEtid obsèvasyon
- University of Pittsburgh Medical Center, Pittsburgh
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
Ap rekriteFaz 1/2
- Research Site, Pittsburgh
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
Ap rekriteFaz 1/2
- UPMC - Hillman Cancer Center, Pittsburgh
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Ap rekriteFaz 3
- UPMC Hillman Cancer Center - Magee-Women?s Hospital, Pittsburgh
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Ap rekriteFaz 3
- Allegheny General Hospital, Pittsburgh
- UPMC-Magee Womens Hospital, Pittsburgh
- West Penn Hospital, Pittsburgh
- ak 10 plis
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
Ap rekriteFaz 1
- UPMC Hillman Cancer Center, Pittsburgh
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Ap rekriteFaz 1
- UPMC, Pittsburgh
ATEMPT 2.0: Adjuvant T-DM1 vs TH
Ap rekriteFaz 2
- University of Pittsburgh Medical Center Cancer UPMC- Magee Women's Hospital, Pittsburgh
Biennial CEM in Women With a Personal History of Breast Cancer
Ap rekriteVolontè an sante akeyi
- Magee-Womens Hospital, Pittsburgh
- Hillman Cancer Center at Shadyside, Pittsburgh
- UPMC Magee-Womens Imaging - Bethel Park, Bethel Park · 8 mi lwen
- ak 3 plis
EXERT-BC Cardio: Cardio or Conditioning Training With Breast Cancer
Ap rekrite
- AHN Allegheny General Hospital, Pittsburgh
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
Ap rekriteFaz 2/3
- Local Institution - 0360, Pittsburgh
E-Mindfulness Approaches for Living After Breast Cancer
Ap rekriteFaz 3
- UPMC-Magee Womens Hospital, Pittsburgh
- UPMC-Saint Margaret, Pittsburgh
- UPMC Hillman Cancer Center, Pittsburgh
- ak 2 plis
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Ap rekriteFaz 1/2
- Allegheny Health Network, Pittsburgh
Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors
Ap rekriteFaz 1
- UPMC Hillman Cancer Center, Pittsburgh
TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients
Ap rekrite
- University of Pittsburgh, Pittsburgh
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
Ap rekriteFaz 1
- University of Pittsburg Medical Center (UPCM), Pittsburgh
Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
Ap rekriteFaz 1
- UPMC Hillman Cancer Center, Pittsburgh
Proteomics and Radiomics Research of Breast Cancer Markers in Tissue, Interstitial Fluid and Serum
Ap rekriteEtid obsèvasyon
- UPMC St. Margaret, Pittsburgh
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Ap rekriteFaz 3
- Allegheny General Hospital, Pittsburgh
- West Penn Hospital, Pittsburgh
- Jefferson Hospital, Jefferson Hills · 11 mi lwen
- ak 3 plis
A Study for CTC Expression and cfDNA/RNA Assessment in Metastatic Breast Cancer Patients
Ap rekriteEtid obsèvasyon
- UPMC Magee Womens Hospital, Pittsburgh
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Ap rekriteEtid obsèvasyon
- Allegheny Health Network, Pittsburgh
EXERT-BCH Exercise Regimen to Improve Muscle Mass After Treatment of Breast Cancer
Ap rekrite
- Allegheny General Hospital, Pittsburgh
Resistance Training and Post Workout Protein to Improve Body Composition During Neoadjuvant Chemotherapy for Breast Cancer
Ap rekrite
- Allegheny General Hospital, Pittsburgh
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Ap rekriteEtid obsèvasyon
- UPMC Magee - Womens Hospital, Pittsburgh
The Cancer of the Pancreas Screening-5 CAPS5)Study
Ap rekriteFaz 3
- University of Pittsburgh, Pittsburgh
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Ap rekriteEtid obsèvasyon
- Allegheny Health Network, Pittsburgh
- University of Pittsburgh Medical Centers, Pittsburgh
Etid Kansè nan tete nan lòt vil
- New York City, NY136 etid
- Houston, TX126 etid
- Boston, MA112 etid
- Nashville, TN81 etid
- Los Angeles, CA73 etid
- Edison, NJ68 etid
- St. Louis, MO64 etid
- Queens, NY64 etid
- Durham, NC64 etid
- Chicago, IL59 etid
- Philadelphia, PA56 etid
- Dallas, TX55 etid
Lòt etid nan Pittsburgh
- Kansè Poumon ki pa ti selil48 etid
- Kansè (tout kalite)41 etid
- Kansè kolorektal32 etid
- Kansè Metastatik31 etid
- Melanom31 etid
- Kansè ovè30 etid
- Kansè Endomèt23 etid
- Kansè pwostat23 etid
- Kansè poumon23 etid
- Karsinòm selil skuamèz tèt ak kou22 etid
- Akidan serebavaskilè22 etid
- Depresyon22 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.